ENDRA Life Sciences Stock Forecast, Price & News

ENDRA Life Sciences (NASDAQ:NDRA) Frequently Asked Questions

How has ENDRA Life Sciences' stock been impacted by Coronavirus (COVID-19)?

ENDRA Life Sciences' stock was trading at $1.0029 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NDRA shares have decreased by 0.7% and is now trading at $0.9961.
View which stocks have been most impacted by COVID-19.

When is ENDRA Life Sciences' next earnings date?

ENDRA Life Sciences is scheduled to release its next quarterly earnings announcement on Thursday, March 24th 2022.
View our earnings forecast for ENDRA Life Sciences.

How were ENDRA Life Sciences' earnings last quarter?

ENDRA Life Sciences Inc. (NASDAQ:NDRA) posted its quarterly earnings data on Monday, November, 15th. The company reported ($0.06) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.01. During the same period in the previous year, the business earned ($0.15) EPS.
View ENDRA Life Sciences' earnings history.

Who are ENDRA Life Sciences' key executives?

ENDRA Life Sciences' management team includes the following people:

• Francois Michelon, Chairman, President & Chief Executive Officer
• Irina Pestrikova, Chief Financial Officer & Senior Director-Finance
• Michael Thornton, Chief Technology Officer (LinkedIn Profile)
• Amy Sitzler, Vice President-Engineering & Programs
• Renaud Maloberti, Chief Commercial Officer

Who are some of ENDRA Life Sciences' key competitors?

Some companies that are related to ENDRA Life Sciences include Movano (MOVE), FONAR (FONR), BioSig Technologies (BSGM), Electromed (ELMD), IRIDEX (IRIX), Second Sight Medical Products (EYES), Soleno Therapeutics (SLNO), electroCore (ECOR), Fc Global Realty (FCRE), Precision Optics (PEYE), Yubo International Biotech (YBGJ), Helius Medical Technologies (HSDT), Viveve Medical (VIVE), Nuwellis (NUWE) and Positron (POSC).
View all of NDRA's competitors.

What other stocks do shareholders of ENDRA Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ENDRA Life Sciences investors own include Advanced Micro Devices (AMD), Trevena (TRVN), VBI Vaccines (VBIV), Ampio Pharmaceuticals (AMPE), Bionano Genomics (BNGO), OPKO Health (OPK), TherapeuticsMD (TXMD), Vista Gold (VGZ), electroCore (ECOR) and Genocea Biosciences (GNCA).

When did ENDRA Life Sciences IPO?

(NDRA) raised $10 million in an initial public offering (IPO) on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO.

What is ENDRA Life Sciences' stock symbol?

ENDRA Life Sciences trades on the NASDAQ under the ticker symbol "NDRA."

Who are ENDRA Life Sciences' major shareholders?

ENDRA Life Sciences' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (0.77%), Royal Bank of Canada (0.04%) and Citadel Advisors LLC (0.04%). Company insiders that own ENDRA Life Sciences stock include Alexander Y Tokman, Anthony Digiandomenico, David R Wells, Francois Roger Michelon, Lou Basenese, Michael Milos Thornton and Renaud Bertrand Maloberti.
View institutional ownership trends for ENDRA Life Sciences.

Which major investors are selling ENDRA Life Sciences stock?

NDRA stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada. Company insiders that have sold ENDRA Life Sciences company stock in the last year include Alexander Y Tokman, David R Wells, Francois Roger Michelon, Lou Basenese, Michael Milos Thornton, and Renaud Bertrand Maloberti.
View insider buying and selling activity for ENDRA Life Sciences or view top insider-selling stocks.

Which major investors are buying ENDRA Life Sciences stock?

NDRA stock was bought by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, and Geode Capital Management LLC. Company insiders that have bought ENDRA Life Sciences stock in the last two years include Anthony Digiandomenico, and Lou Basenese.
View insider buying and selling activity for ENDRA Life Sciences or or view top insider-buying stocks.

How do I buy shares of ENDRA Life Sciences?

Shares of NDRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ENDRA Life Sciences' stock price today?

One share of NDRA stock can currently be purchased for approximately $1.00.

How much money does ENDRA Life Sciences make?

ENDRA Life Sciences has a market capitalization of $42.00 million and generates $10 thousand in revenue each year. The company earns $-11.73 million in net income (profit) each year or ($0.39) on an earnings per share basis.

How many employees does ENDRA Life Sciences have?

ENDRA Life Sciences employs 18 workers across the globe.

What is ENDRA Life Sciences' official website?

The official website for ENDRA Life Sciences is www.endrainc.com.

Where are ENDRA Life Sciences' headquarters?

ENDRA Life Sciences is headquartered at 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105.

How can I contact ENDRA Life Sciences?

ENDRA Life Sciences' mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company can be reached via phone at (734) 335-0468 or via email at [email protected].